Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Synthorx Inc (THOR)

Synthorx Inc (THOR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,198,661
  • Shares Outstanding, K 32,338
  • Annual Sales, $ 0 K
  • Annual Income, $ -56,610 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 14.44
Trade THOR with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.12
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 03/10/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.43
  • Number of Estimates 3
  • High Estimate -0.39
  • Low Estimate -0.47
  • Prior Year -0.89
  • Growth Rate Est. (year over year) +51.69%

Price Performance

See More
Period Period Low Period High Performance
1-Month
67.82 +0.25%
on 12/23/19
71.90 -5.44%
on 12/27/19
-0.03 (-0.04%)
since 12/20/19
3-Month
11.05 +515.29%
on 10/29/19
71.90 -5.44%
on 12/27/19
+55.31 (+436.20%)
since 10/22/19
52-Week
11.05 +515.29%
on 10/29/19
71.90 -5.44%
on 12/27/19
+53.00 (+353.57%)
since 01/22/19

Most Recent Stories

More News
IBKC, THOR, TIF, and AMTD SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts

WILMINGTON, Del., Jan. 09, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating:

IBKC : 43.08 (-5.40%)
THOR : 67.99 (unch)
TIF : 131.46 (unch)
AMTD : 1.1600 (unch)
INVESTIGATION ALERT: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders - INST, THOR, LOGM

INVESTIGATION ALERT: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders - INST, THOR, LOGM

INST : 22.05 (-2.86%)
THOR : 67.99 (unch)
LOGM : 86.04 (unch)
WAAS, TIVO, THOR, and CRCM SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts

WILMINGTON, Del., Jan. 07, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating:

WAAS : 27.03 (-0.11%)
TIVO : 6.09 (-4.99%)
THOR : 67.99 (unch)
CRCM : 15.00 (+0.07%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders - HABT, INST, THOR

NEW YORK, NY / ACCESSWIRE / January 6, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies:

HABT : 13.98 (+0.94%)
INST : 22.05 (-2.86%)
THOR : 67.99 (unch)
CBB, TGE, INST, and THOR SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts

WILMINGTON, Del., Jan. 02, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating:

CBB : 15.48 (-0.06%)
TGE : 22.39 (unch)
INST : 22.05 (-2.86%)
THOR : 67.99 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Synthorx Inc. is a biopharmaceutical company which focuses on cancer and autoimmune disorders. The company's product pipeline consists of THOR-707, IL-2 autoimmune synthorin, IL-10 synthorin and IL-15 synthorin which are in clinical stage. Synthorx Inc. is based in La Jolla, CA.

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 68.02
1st Resistance Point 68.00
Last Price 67.99
1st Support Level 67.98
2nd Support Level 67.98
3rd Support Level N/A

See More

52-Week High 71.90
Last Price 67.99
Fibonacci 61.8% 48.66
Fibonacci 50% 41.48
Fibonacci 38.2% 34.29
52-Week Low 11.05

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar